These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 38113522

  • 1. Filter Lifespan, Treatment Effect, and Influencing Factors of Continuous Renal Replacement Therapy for Severe Burn Patients.
    Yue Q, Wu H, Xi M, Li F, Li T, Li Y.
    J Burn Care Res; 2024 May 06; 45(3):764-770. PubMed ID: 38113522
    [Abstract] [Full Text] [Related]

  • 2. Nafamostat mesilate for anticoagulation in continuous renal replacement therapy.
    Hwang SD, Hyun YK, Moon SJ, Lee SC, Yoon SY.
    Int J Artif Organs; 2013 Mar 06; 36(3):208-16. PubMed ID: 23404639
    [Abstract] [Full Text] [Related]

  • 3. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study.
    Liu D, Zhao J, Xia H, Dong S, Yan S, Zhuang Y, Chen Y, Peng H.
    Eur J Med Res; 2024 Jan 20; 29(1):72. PubMed ID: 38245802
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Anticoagulant Effect of Low-Molecular-Weight Heparin Sodium and Sodium Citrate on Patients with Severe Acute Kidney Injury Treated by Continuous Renal Replacement Therapy.
    Meng Y, Xie C, Lin Z, Yuxiang Xie.
    Iran J Kidney Dis; 2024 Aug 20; 18(4):221-226. PubMed ID: 39423094
    [Abstract] [Full Text] [Related]

  • 5. [Effects of regional citrate anticoagulation in continuous veno-venous hemofiltration of severe burn patients].
    Wang ZY, Feng SH, Fan BL, Ma W, Jia XC, Geng H.
    Zhonghua Shao Shang Za Zhi; 2021 Dec 20; 37(12):1137-1142. PubMed ID: 34839601
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE.
    Crit Care; 2021 Aug 19; 25(1):299. PubMed ID: 34412667
    [Abstract] [Full Text] [Related]

  • 10. Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients.
    Zhang W, Bai M, Zhang L, Yu Y, Li Y, Zhao L, Yue Y, Li Y, Zhang M, Fu P, Sun S, Chen X.
    Blood Purif; 2022 Aug 19; 51(8):668-678. PubMed ID: 34673634
    [Abstract] [Full Text] [Related]

  • 11. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study.
    Li L, Bai M, Zhang W, Zhao L, Yu Y, Sun S.
    Int J Artif Organs; 2022 Apr 19; 45(4):343-350. PubMed ID: 33784842
    [Abstract] [Full Text] [Related]

  • 12. Regional citrate anticoagulation for continuous renal replacement therapy in severe burns-a retrospective analysis of a protocol-guided approach.
    Gille J, Sablotzki A, Malcharek M, Raff T, Mogk M, Parentin T.
    Burns; 2014 Dec 19; 40(8):1593-601. PubMed ID: 24612996
    [Abstract] [Full Text] [Related]

  • 13. Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
    Kameda S, Fujii T, Ikeda J, Kageyama A, Takagi T, Miyayama N, Asano K, Endo A, Uezono S.
    BMC Nephrol; 2023 Jan 16; 24(1):12. PubMed ID: 36642717
    [Abstract] [Full Text] [Related]

  • 14. The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.
    Baek NN, Jang HR, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    Ren Fail; 2012 Jan 16; 34(3):279-85. PubMed ID: 22251267
    [Abstract] [Full Text] [Related]

  • 15. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH.
    Nephron Clin Pract; 2004 Jan 16; 97(4):c131-6. PubMed ID: 15331942
    [Abstract] [Full Text] [Related]

  • 16. A Comparison of the Anticoagulation Efficacy and Safety of Epoprostenol to Heparin and Citrate in Children Receiving Continuous Renal Replacement Therapy.
    Sondhi E, Stewart M, Harper J, Konyk L, McSteen C, Crowley KL, Kim-Campbell N, Fabio A, Fuhrman DY.
    Blood Purif; 2024 Jan 16; 53(10):838-846. PubMed ID: 38991509
    [Abstract] [Full Text] [Related]

  • 17. [Effects of citric acid on patients with severe burn complicated with acute renal injury treated by continuous renal replacement therapy].
    Li XL, Xiao HT, Li YC, Li YG, Zhang J, Feng K, Di HP, Tian SM, Lou JH, Xia CD.
    Zhonghua Shao Shang Za Zhi; 2019 Aug 20; 35(8):568-573. PubMed ID: 31474035
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P.
    Crit Care; 2023 Jun 07; 27(1):222. PubMed ID: 37287084
    [Abstract] [Full Text] [Related]

  • 19. [Application effects of bundle nursing of citric acid extracorporeal anticoagulation on continuous renal replacement therapy of severe burn patients].
    Li N, Chen HL, Li MJ, Luo GX, Yuan ZQ.
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Jan 20; 38(1):29-37. PubMed ID: 34954935
    [Abstract] [Full Text] [Related]

  • 20. Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy.
    Miyaji MJ, Ide K, Takashima K, Maeno M, Krallman KA, Lazear D, Goldstein SL.
    Pediatr Nephrol; 2022 Nov 20; 37(11):2733-2742. PubMed ID: 35348901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.